Skip to main content

Table 1 Characteristic of patients

From: Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy

  Median Mean Range
Age (years) 77 76.5 53-95
Follow-up period (months) 49 52.0 12-143
PSA level at diagnosis (ng/mL) 15 28.9 1.4-200